Daily administration of either phenobarbital (60 mg/kg) or yin zhi huang (YZH,30-60 ml/kg) for 5 days to rats similarly accelerated the clearance and conjugation of intravenously infused bilirubin. However, the two drugs had quite different effects on liver enzyme activities associated with xenobiotic metabolism and with bilirubin metabolism. Phenobarbital markedly increased cytochrome P-450 levels and the cytochrome-P-450-mediated formation of 4-hydroxybiphenyl whereas YZH had a slightly depressive effect on this enzyme system. Both drugs increased glucuronyl transferase activity using bilirubin andα-naphthol as substrates. Bilirubin conjugation in microsomes activated by uridine diphosphate-N-acetylglucosamine (NAG) was greater in YZH- than in phenobarbital-treated rats whereas phenobarbital was a more effective inducer in digitonin-activated enzyme. Whenα-naphthol was used as substrate (NAG-activated glucuronyl transferase), pretreatment with phenobarbital produced a greater increase in activity than did YZH. Glutathione-S-transferase activity (using chlorodinitrobenzene as substrate) was increased more than 2-fold by phenobarbital but only slightly (1.29 ×) by YZH. In contrast, YZH (60 ml/kg) was more effective than phénobarbital in increasing glutathione peroxidase activity using cumene hydroperoxide as substrate. YZH appears to be a relatively specific inducer of enzymes involved in bilirubin metabolism.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.